Clostridium Infections: Infections with bacteria of the genus CLOSTRIDIUM.Clostridium: A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.Click Chemistry: Organic chemistry methodology that mimics the modular nature of various biosynthetic processes. It uses highly reliable and selective reactions designed to "click" i.e., rapidly join small modular units together in high yield, without offensive byproducts. In combination with COMBINATORIAL CHEMISTRY TECHNIQUES, it is used for the synthesis of new compounds and combinatorial libraries.Questionnaires: Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.Clostridium difficile: A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis (ENTEROCOLITIS, PSEUDOMEMBRANOUS) in patients receiving antibiotic therapy.Glycosides: Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed)Time Factors: Elements of limited time intervals, contributing to particular results or situations.Enterocolitis, Pseudomembranous: An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.Soaps: Sodium or potassium salts of long chain fatty acids. These detergent substances are obtained by boiling natural oils or fats with caustic alkali. Sodium soaps are harder and are used as topical anti-infectives and vehicles in pills and liniments; potassium soaps are soft, used as vehicles for ointments and also as topical antimicrobials.Ribotyping: RESTRICTION FRAGMENT LENGTH POLYMORPHISM analysis of rRNA genes that is used for differentiating between species or strains.CarbanilidesBacterial Toxins: Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.Biological Therapy: Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.Research Support, U.S. Gov't, Non-P.H.S.Research Support, U.S. Gov't, P.H.S.Microbiota: The full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within a particular biological niche such as an organism, soil, a body of water, etc.Feces: Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.Intestines: The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.Medicine in ArtOregonAccess to Information: Individual's rights to obtain and use information collected or generated by others.Antidepressive Agents: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.Recurrence: The return of a sign, symptom, or disease after a remission.Evidence-Based Medicine: An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006)Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.Telephone: An instrument for reproducing sounds especially articulate speech at a distance. (Webster, 3rd ed)Enema: A solution or compound that is introduced into the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.Cardiology: The study of the heart, its physiology, and its functions.Sleep Medicine Specialty: A medical specialty concerned with the diagnosis and treatment of SLEEP WAKE DISORDERS and their causes.Emergency Medicine: The branch of medicine concerned with the evaluation and initial treatment of urgent and emergent medical problems, such as those caused by accidents, trauma, sudden illness, poisoning, or disasters. Emergency medical care can be provided at the hospital or at sites outside the medical facility.Gastroenterology: A subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures (esophagus, liver, gallbladder, and pancreas).Endocrinology: A subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the ENDOCRINE SYSTEM.Nephrology: A subspecialty of internal medicine concerned with the anatomy, physiology, and pathology of the kidney.Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed).Megacolon, Toxic: An acute form of MEGACOLON, severe pathological dilatation of the COLON. It is associated with clinical conditions such as ULCERATIVE COLITIS; CROHN DISEASE; AMEBIC DYSENTERY; or CLOSTRIDIUM ENTEROCOLITIS.Proton Pump Inhibitors: Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.Megacolon: Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON.Enterotoxins: Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria.Compassionate Use Trials: Providing an investigational therapy to a patient who is not eligible to receive that therapy in a clinical trial, but who has a serious or life-threatening illness for which other treatments are not available. Compassionate use trials allow patients to receive promising but not yet fully studied or approved therapies when no other treatment option exists. Also called expanded access trial.Vancomycin: Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.Trinidad and Tobago: An independent state in the Lesser Antilles in the West Indies, north of Venezuela, comprising the islands of Trinidad and Tobago. Its capital is Port of Spain. Both islands were discovered by Columbus in 1498. The Spanish, English, Dutch, and French figure in their history over four centuries. Trinidad and Tobago united in 1898 and were made part of the British colony of Trinidad and Tobago in 1899. The colony became an independent state in 1962. Trinidad was so named by Columbus either because he arrived on Trinity Sunday or because three mountain peaks suggested the Holy Trinity. Tobago was given the name by Columbus from the Haitian tambaku, pipe, from the natives' habit of smoking tobacco leaves. (Webster's New Geographical Dictionary, 1988, p1228, 1216 & Room, Brewer's Dictionary of Names, 1992, p555, 547)Clostridium perfringens: The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins.Gas Gangrene: A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases (over eighty percent), while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases.Information Centers: Facilities for collecting and organizing information. They may be specialized by subject field, type of source material, persons served, location, or type of services.Internet: A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.Rare Diseases: A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.National Health Planning Information Center (U.S.): A center in the HEALTH RESOURCES ADMINISTRATION Division of Planning Methods and Technology which provides access to current information on health planning and resources development.Hemofiltration: Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function.Cefazolin: A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.

Characteristics of a strain of Clostridium carnis causing septicaemia in a young infant. (1/851)

Clostridium carnis is a species which is only rarely isolated from man or animals and is occasionally found in the soil. This paper is an account of a single isolate found in blood cultures obtained from an 8-week-old boy who was suffering from gastroenteritis.  (+info)

Hemorrhagic enteritis associated with Clostridium perfringens type A in a dog. (2/851)

A female Shetland sheep dog died suddenly with hemorrhagic diarrhea and vomitting, and was examined pathologically and microbiologically. Gross pathological change was restricted to the intestinal tract. The intestine contained watery, blood-stained fluid. Histopathologically, the principal intestinal lesion was superficial mucosal hemorrhagic necrosis at the jejunoileum. Many Gram-positive bacilli were found adhering to the necrotic mucosal surface in parts of the intestinal tract. Clostridium perfringens in pure culture were isolated from jejunal contents by anaerobic culture. These results suggested that the typical lesion of this case coincided with canine hemorrhagic enteritis and enterotoxemia due to C. perfringens infection could be the cause of sudden death.  (+info)

Naturally occurring Tyzzer's disease in a calf. (3/851)

Naturally occurring Clostridium piliforme infection (Tyzzer's disease) was found in a calf. Light microscopic examination revealed multifocal coagulative necrosis in the liver, catarrhal gastroenteritis, tracheitis and pneumonia, and thymic atrophy. Warthin-Starry staining clearly showed large filamentous bacilli in bundles or criss-cross patterns within the hepatocytes and epithelium and smooth muscle cells of the ileum and cecum. Immunohistochemistry using anti-C. piliforme RT and MSK strain antisera showed positive reaction against the bacilli. Electron microscopic examination revealed bacilli within the hepatocytes that demonstrated a characteristic vegetative form, with peritrichous flagella, and spores. The polymerase chain reaction (PCR) study using the paraffin-embedded liver sections, the 196-bp DNA fragment specific to 16S ribosomal RNA of C. piliforme was amplified. The characteristics of these bacilli are consistent with those of of C. piliforme. The PCR technique using paraffin-embedded sections should be useful for confirming C. piliforme infection in spontaneous cases.  (+info)

Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. (4/851)

To obtain high yields of extracellular enzymes and toxins for immunological analysis, type culture collection strains of Clostridium perfringens types A to D and 28 fresh isolates of C. perfringens type A from humans were grown in fermenters under controlled conditions in a pre-reduced proteose peptone medium. The type culture collection strains all showed different characteristics with respect to growth rates and pH optima for growth. Production of phospholipase C (alpha-toxin), haemolysin and lethal activity varied considerably between the different types. Growth and extracellular protein production in fermenters with pH control and static or stirred cultures were compared. Production of all extracellular proteins measured was markedly improved by cultivation in fermenters with pH control. Strain ATCC13124 produced five times more phospholipase C than any of 28 freshly isolated strains of C. perfringens type A, grown under identical conditions. Haemolytic and lethal activities of the ATCC strain were equal or superior to the activities of any of the freshly isolated strains. There were no differences in the bacterial yields and in the production of extracellular toxins between type A strains isolated from clinical cases of gas gangrene and abdominal wounds, and those isolated from faecal samples from healthy persons.  (+info)

Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. (5/851)

OBJECTIVE: toxigenic Clostridium difficile is responsible for a spectrum of disease severity ranging from mild diarrhoea to fulminant colitis. This study attempts to determine the proportion of patients in each category of severity and evaluate the risk factors for a more prolonged and complicated course. DESIGN: prospective cohort study. SETTING: university teaching hospital. SUBJECTS: all patients with symptomatic C. difficile infection during 4 months of an outbreak (January-April 1995); n=73; median age 74 years (range 17-91). MEASUREMENTS: incidence of C. difficile-associated disease (CDAD); severity of disease; percentage of patients in each category of severity; risk factors for severe disease/prolonged symptoms (univariate and multivariable analyses). RESULTS: the incidence of CDAD was 0.93%. Of the cases identified, 18 (24.7%) had mild, self-limiting disease; 26 (35.6%) had moderately severe disease; 23 (31.5%) had prolonged symptoms and six (8.2%) had a complicated course. Although CDAD was more common in older patients (P < 0.001), increasing age was not a risk factor for severity. Significant risk factors for severe CDAD included low Barthel and abbreviated mental test scores (P < 0.01, P < 0.001 respectively) and recent endoscopy (P=0.03). Logistic regression analysis revealed the following independent predictors of severe CDAD: endoscopy [odds ratios (OR) 4.0, P=0.03] and cognitive impairment (OR 11.0, P < 0.01). A trend towards significance was noted for nasogastric tube insertion (OR 3.1, P=0.08). Complications of infection included dehydration, malnutrition and faecal incontinence (which was statistically significantly associated with more severe disease; P < 0.01). CONCLUSION: risk factors for severity of CDAD include functional disability, cognitive impairment, and recent endoscopy. Anticipation of severe CDAD may limit morbidity and mortality.  (+info)

Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate food-borne-disease outbreak investigations. (6/851)

Clostridium perfringens is a common cause of food-borne illness. The illness is characterized by profuse diarrhea and acute abdominal pain. Since the illness is usually self-limiting, many cases are undiagnosed and/or not reported. Investigations are often pursued after an outbreak involving large numbers of people in institutions, at restaurants, or at catered meals. Serotyping has been used in the past to assist epidemiologic investigations of C. perfringens outbreaks. However, serotyping reagents are not widely available, and many isolates are often untypeable with existing reagents. We developed a pulsed-field gel electrophoresis (PFGE) method for molecular subtyping of C. perfringens isolates to aid in epidemiologic investigations of food-borne outbreaks. Six restriction endonucleases (SmaI, ApaI, FspI, MluI, KspI, and XbaI) were evaluated with a select panel of C. perfringens strains. SmaI was chosen for further studies because it produced 11 to 13 well-distributed bands of 40 to approximately 1,100 kb which provided good discrimination between isolates. Seventeen distinct patterns were obtained with 62 isolates from seven outbreak investigations or control strains. In general, multiple isolates from a single individual had indistinguishable PFGE patterns. Epidemiologically unrelated isolates (outbreak or control strains) had unique patterns; isolates from different individuals within an outbreak had similar, if not identical, patterns. PFGE identifies clonal relationships of isolates which will assist epidemiologic investigations of food-borne-disease outbreaks caused by C. perfringens.  (+info)

Differences in the carboxy-terminal (Putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymes. (7/851)

The phospholipases C of C. perfringens (alpha-toxin) and C. bifermentans (Cbp) show >50% amino acid homology but differ in their hemolytic and toxic properties. We report here the purification and characterisation of alpha-toxin and Cbp. The phospholipase C activity of alpha-toxin and Cbp was similar when tested with phosphatidylcholine in egg yolk or in liposomes. However, the hemolytic activity of alpha-toxin was more than 100-fold that of Cbp. To investigate whether differences in the carboxy-terminal domains of these proteins were responsible for differences in the hemolytic and toxic properties, a hybrid protein (NbiCalpha) was constructed comprising the N domain of Cbp and the C domain of alpha-toxin. The hemolytic activity of NbiCalpha was 10-fold that of Cbp, and the hybrid enzyme was toxic. These results confirm that the C-terminal domain of these proteins confers different properties on the enzymatically active N-terminal domain of these proteins.  (+info)

Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins. (8/851)

Clostridium tertium was isolated from two immunocompromised patients with septicemia, fever, and gastrointestinal symptoms. The strains were resistant to ceftazidime, cefepime, and clindamycin; intermediately resistant to penicillin; and susceptible to metronidazole, quinolones, and vancomycin.  (+info)

*Clostridium difficile infection

... (CDI) is a symptomatic infection due to the spore-forming bacterium, Clostridium difficile. ... "Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update". Infection Control and Hospital ... "Clostridium difficile Infection Information for Patients , HAI , CDC". www.cdc.gov. Archived from the original on 30 March 2017 ... "Clostridium difficile Infection Information for Patients , HAI , CDC". www.cdc.gov. Archived from the original on 16 December ...

*Mallard

Clostridium Infections: Advances in Research and Treatment: 2011 Edition: ScholarlyPaper. ScholarlyEditions. 9 January 2012. ...

*Large-billed crow

Large scale deaths have also been noted to be caused by Clostridium infection and enteritis. BirdLife International (2012). " ... Pathology of Fatal Highly Pathogenic H5N1 Avian Influenza Virus Infection in Large-billed Crows (Corvus macrorhynchos) during ... Fatal necrotic enteritis associated with Clostridium perfringens in wild crows (Corvus macrorhynchos). Avian Pathology 33(1):19 ...

*Australian raven

Wounded lambs can also succumb to Clostridium infection as these bacteria are present on raven bills. Ravens bring some ...

*Human feces

Clostridium difficile infection. Malabsorption Short bowel syndrome Attempts to reduce the odor of feces (and flatus) are ... "Treating Clostridium difficile Infection With Fecal Microbiota Transplantation". Clinical Gastroenterology and Hepatology. 9 ( ... Diarrhea is most commonly caused by a myriad of viral infections but is also often the result of bacterial toxins and sometimes ... Yellowing of feces can be caused by an infection known as giardiasis, which derives its name from Giardia, an anaerobic ...

*Gas gangrene

Bratton SL, Krane EJ, Park JR, Burchette S (1992). "Clostridium septicum infections in children". Pediatr Infect Dis J. 11 (7 ... Unlike other anaerobic infections, discharge in these infections is often not purulent (filled with pus). Instead, the ... "Gas gangrene in an immunocompromised girl due to a Clostridium ramosum infection". Clin. Infect. Dis. 28 (4): 923-4. doi: ... Gangrenous infection by soil-borne bacteria was common in the combat injuries of soldiers well into the 20th century, because ...

*Bison

... in the Antelope Island bison herd are regularly inoculated against brucellosis, parasites, Clostridium infection, ...

*Colestyramine

... can be helpful in the treatment of Clostridium difficile infections, to absorb toxins A and B, and reduce the ... Stroehlein JR (June 2004). "Treatment of Clostridium difficile Infection". Curr Treat Options Gastroenterol. 7 (3): 235-239. ...

*Dietary fiber

Ward PB, Young GP (1997). "Dynamics of Clostridium difficile infection. Control using diet". Adv Exp Med Biol. 412: 63-75. PMID ... and Clostridium difficile, due in part to the short-chain fatty acids produced with subsequent anti-inflammatory actions upon ...

*Fecal microbiota transplant

Fecal Bacteriotherapy in the treatment of recurrent Clostridium difficile infection. UpToDate Eiseman B, Silen W, Bascom GS, et ... Kelly CR; De Leon L; Jasutkar N (2012). "Fecal Microbiota Transplantation for relapsing Clostridium difficile infection in 26 ... Burke KE, Lamont JT (August 2013). "Fecal Transplantation for Recurrent Clostridium difficile Infection in Older Adults: A ... Video: ABC TV Catalyst, 14 July 2011 - Fecal Bacteriotherapy for Clostridium difficile infection Bibbò, S; Ianiro, G; ...

*Fidaxomicin

"Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes". Journal of Infection. 58 (6): ... The target use is for treatment of Clostridium difficile infection. Fidaxomicin is available in a 200 mg tablet that is ... The maintenance of normal physiological conditions in the colon can reduce the probability of Clostridium difficile infection ... September 12-15, 2009). Safety of fidaxomicin versus vancomycin in treatment of Clostridium difficile infection. 49th ...

*Neutropenic enterocolitis

"Neutropenic enterocolitis due to Clostridium septicum infection". J Clin Pathol. 37: 335-43. doi:10.1136/jcp.37.3.335. PMC ... The condition is usually caused by Gram-positive enteric commensal bacteria of the gut (gut flora). Clostridium difficile is a ... whereas Clostridium septicum is responsible for most cases of neutropenic enterocolitis. Typhlitis most commonly occurs in ... particularly if the patient is neutropenic or at other risk of infection. In rare cases of prolonged neutropenia and ...

*Clostridium septicum

... but unlike other Clostridium species like Clostridium perfringens, no trauma is necessary at the site of the infection. It is ... Infection and Immunity. 60 (3): 784-790. Alpern, RJ; Dowell, VR (1969). "Clostridium septicum infections and malignancy". JAMA ... Oct 1995). "Clostridium septicum infection". Surgery. 118 (4): 592-8. doi:10.1016/s0039-6060(05)80023-6. *Mahon, Connie R.; ... ISBN 0-7216-7917-X. Smith-Slatas CL, Bourque M and Salazar JC (2006). Clostridium septicum infections in children: a case ...

*Ebselen

Additionally, ebselen may be effective against Clostridium difficile infections. Ebselen is a potent scavenger of hydrogen ...

*Clostridium colinum

Perelman, B; Mints, S; Zjut, M; Kuttin, E; Machny, S (September 1991). "An unusual Clostridium colinum infection in broiler ... Clostridium colinum can cause ulcerative enteritis in chicken. Parte, A.C. "Clostridium". www.bacterio.net. "Clostridium ... Clostridium colinum is a Gram-positive, anaerobic and spore-forming bacterium from the genus of Clostridium which has been ... "Nomenclature Abstract for Clostridium colinum (ex Berkhoff et al. 1974) Berkhoff 1985". The NamesforLife Abstracts. doi:10.1601 ...

*Evolutionary pressure

Terrier M. C. Z., Simonet M. L., Bichard P., Frossard J. L. (2014). "Recurrent Clostridium difficile infections: The importance ... Dawson L.F., Valiente E., Wren B.W. (2009). "Clostridium difficile-A continually evolving and problematic pathogen. Infections ... Clostridium difficile, gram-positive bacteria species that inhabits the gut of mammals, exemplifies one type of bacteria that ... is a major cause of death by nosocomial infections. When symbiotic gut flora populations are disrupted (e.g., by antibiotics), ...

*Diarrhea

Rupnik M, Wilcox MH, Gerding DN (July 2009). "Clostridium difficile infection: new developments in epidemiology and ... It can be caused by bacterial infections, viral infections, parasitic infections, or autoimmune problems such as inflammatory ... These infections are often acquired from food or water that has been contaminated by feces, or directly from another person who ... The most common cause is an infection of the intestines due to either a virus, bacteria, or parasite - a condition also known ...

*Janet Hiller

"The prolongation of length of stay because of Clostridium difficile infection". Am J Infect Control. 42 (2): 164-167. doi: ...

*Norfloxacin

Slimings C, Riley TV (December 2013). "Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic ... September 2013). "Community-associated Clostridium difficile infection and antibiotics: a meta-analysis". J. Antimicrob. ... It is used to treat urinary tract infections, gynecological infections, inflammation of the prostate gland, gonorrhea and ... "Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis". Int. J. Infect. ...

*Quinolone antibiotic

Slimings C, Riley TV (December 2013). "Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic ... September 2013). "Community-associated Clostridium difficile infection and antibiotics: a meta-analysis". Journal of ... Only inhalant anthrax and pseudomonal infections in cystic fibrosis infections are licensed indications in the UK due to ... "Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis". International ...

*Ofloxacin

Slimings C, Riley TV (December 2013). "Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic ... September 2013). "Community-associated Clostridium difficile infection and antibiotics: a meta-analysis". J. Antimicrob. ... "Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis". Int. J. Infect. ... labelled for use in adults with lower respiratory tract infections, skin and skin structure infections, urinary tract ...

*Saccharomyces boulardii

... with recurrent Clostridium difficile infection and may be effective for secondary prevention of Clostridium difficile infection ... Tung, Jennifer M; Dolovich, Lisa R; Lee, Christine H (December 2009). "Prevention of Clostridium difficile infection with ... Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea". J Clin Gastroenterol. 42 ( ... The addition of S. boulardii to the standard triple medication protocol for elimination of Helicobacter pylori infection showed ...

*Doripenem

Infection related: use of doripenem can lead to clostridium difficile infection. It has also been noted to increase mortality ... Doripenem can be used for bacterial infections such as: complex abdominal infections, pneumonia within the setting of a ... and complicated infections of the urinary tract including kidney infections with septicemia. Doripenem decreases the process of ... "FDA Approves New Drug to Treat Complicated Urinary Tract and Intra-Abdominal Infections" (Press release). U.S. Food and Drug ...

*Yeast

S. boulardii has been shown to reduce the symptoms of acute diarrhea, reduce the chance of infection by Clostridium difficile ( ... "Is primary prevention of Clostridium difficile infection possible with specific probiotics?". International Journal of ... Other species of yeasts, such as Candida albicans, are opportunistic pathogens and can cause infections in humans. Yeasts have ... Yeasts of the Candida genus, another group of opportunistic pathogens, cause oral and vaginal infections in humans, known as ...

*Black tar heroin

Tar heroin injection can also be associated with Clostridium botulinum infection. In some parts of the United States, ... At least one study has drawn attention to lower rates of HIV infection amongst drug injectors in which black tar heroin is the ... may put people who inject it at a lower risk of HIV infection because they may be forced to inject subcutaneously (rather than ... black tar heroin injectors can be at increased risk of life-threatening bacterial infections, in particular necrotizing soft ...

*Metabolism

"Metabolic engineering of Clostridium acetobutylicum for the industrial production of 1,3-propanediol from glycerol". Metab Eng ... have been validated as important during various stages of the infection lifecycle of M. tuberculosis. Amino acids are either ...
By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by clicking here. If you do not currently have a user account, and would like to create one/become a member, click here to begin the singup process ...
Title: Clostridium Difficile Infection Following Chemotherapy. VOLUME: 5 ISSUE: 1. Author(s):Shahzad Raza, Mahadi A. Baig, Helena Russell, Yanick Gourdet and Barbara J. Berger. Affiliation:Department of Medicine Brookdale University Hospital and Medical Center, New York, USA.. Keywords:Chemotherapy, glutamate dehydrogenase test, real-time polymerase chain reaction, enzyme immunoassays, Clostridium difficile infection. Abstract: Clostridium difficile infection (CDI) is a major concern for health care system and clinicians. Interest in C. difficile infection has increased recently due to an ongoing C. difficile epidemic with a hypervirulent strain and mortality. Disease due to C. difficile is responsible for substantial strain on the hospital system by increasing patients length of stay and increasing costs. Present studies have demonstrated chemotherapeutic agents as an independent risk factor for CDI potentially leading towards serious morbidity and mortality. However, the current strategies ...
New advances in the treatment of Clostridium difficile infection (CDI) Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K FarverSouth Dakota State University College of Pharmacy, Brookings, SD 57007, USAAbstract: Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have been linked to a hypervirulent C. difficile strain resulting in greater severity of disease. Although most mild to moderate cases of CDI continue to respond to metronidazole or vancomycin, refractory and recurrent cases of CDI may require alternative therapies. This review provides a brief overview of CDI and summarizes studies involving alternative antibiotics, toxin binders, probiotics, and immunological therapies that can be considered for treatment of acute and recurrent CDI in severe and refractory situations.Keywords: Clostridium difficile, antibiotics, probiotics, immunological therapy
Clostridium difficile infections cause morbidity and mortality. The authors conducted a retrospective review of Clostridium difficile infection (CDI) in kidney transplant recipients at their center over a 3 year period. The overall rate of CDI was 6.1% and increased over time during the study. A case-control study was subsequently performed to determine the risk factors for infection. Independent predictors of CDI among kidney transplant recipients were VRE colonization, having a CDC-criteria high risk donor, and administration of high-risk antibiotics such as antipseudomonal penicillins and carbapenems. There were no deaths in this series although 10.8% had recurrent infection. The study highlights the need for judicious antibiotic use and good infection control practices in transplant units.. ...
1. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-34. doi: 10.1056/NEJMoa1408913 25714160. 2. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA internal medicine. 2013;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056 23780507. 3. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, OConnor L, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. The New England journal of medicine. 2013;369(13):1195-205. doi: 10.1056/NEJMoa1216064 24066741. 4. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529-49. doi: 10.1128/CMR.00082-09 20610822. 5. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. ...
Clostridium difficile infections (CDI) are the most frequent cause of diarrhoea in hospitals. Geriatric patients are more often affected by the condition, by a relapse and complications. Therefore, a crucial question is how often colonization with toxigenic Clostridium difficile strains occurs in elderly patients without diarrhoea and whether there is a
Background Clostridium difficile is a Gram-positive bacteria found in the large bowel or colon that causes mild to severe intestinal conditions and sometimes death. The primary risk factors for development of Clostridium difficile infection (CDI) include healthcare exposure and recent antimicrobial use. The purpose of this study is to compare risk factors associated with CDI occurring in the Community to those associated with Healthcare Facility Associated CDI in the metro Atlanta population from September 1, 2009 - April 30, 2011. Methods Patients were identified through C. difficile surveillance program of the Georgia Emerging Infections Program (EIP). Prospective, population based, laboratory based surveillance for all positive C. difficile cases in the Georgia Health District 3 (HD3). Due to the sampling scheme, for this analysis CO-HCFA and HCFO cases were combined to make a Healthcare Facility Associated (HCFA) classification. Using SAS, a logistic regression analysis was performed to compare the
A panel of experts was convened by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) to update the 2010 clinical practice guideline on Clostridium difficile infection (CDI) in adults. The update, which has incorporated recommendations for children (following the adult recommendations for epidemiology, diagnosis, and treatment), includes significant changes in the management of this infection and reflects the evolving controversy over best methods for diagnosis. Clostridium difficile remains the most important cause of healthcare-associated diarrhea and has become the most commonly identified cause of healthcare-associated infection in adults in the United States. Moreover, C. difficile has established itself as an important community pathogen.
Glutamate dehydrogenase (GDH), an enzyme present in high copy numbers in many organisms, has proved to be a sensitive screening marker for Clostridium difficile. Since GDH is present in many intestinal bacteria, it is crucial that assay systems for glutamate dehydrogenase be accurate and highly sensitive for the detection of C. difficile-specific GDH. The RIDA®QUICK Clostridium difficile GDH immunochromatographic rapid test meets both of these requirements to a high degree. Although it does not eliminate the need for the detection of C. difficile toxins A and B, which is obligatory for the diagnosis of Clostridium difficile infection, the RIDA®QUICK Clostridium difficile GDH difficile rapid test improves the reliability of detection of this very consequential nosocomial pathogen when performed sequentially, i.e., before or parallel to the RIDA®QUICK Clostridium difficile Toxin A/B rapid test. Both the specific clinical symptoms and signs and the positive detection of C. difficile toxins A and ...
Although mostly associated with antibiotic use in hospitalized patients, C. difficile infections in people in the community have become more common. As of 2014, they accounted for 41 percent of all C. difficile infections, according to the Centers for Disease Control and Prevention (CDC). In this new case-control study, researchers enrolled adult patients from 10 U.S. sites during 2014-2015 who tested positive for C. difficile as an outpatient, or within three days of being hospitalized, and who had not been admitted to a health care facility within the past 12 weeks.. Each patient was matched to a person who did not have a C. difficile infection as a control. All of the study participants-452 total-were interviewed individually by phone to collect information about their health, medication use, recent health care visits, household exposures, and diet. In line with previous studies, larger percentages of patients with community-associated C. difficile infections had prior outpatient health care ...
[115 Pages Report] Check for Discount on United States Drugs for Clostridium Difficile Infections Market Report 2017 report by QYResearch Group. In this report, the United States Drugs for Clostridium Difficile...
title: Epidemiology and clinical features of toxigenic culture-confirmed hospital?onset Clostridium difficile infection: A multicentre prospective study in tertiary hospitals of South Korea, doi: 10.1099/jmm.0.070672-0, category: Article
Certain types of anti-depressants have been linked to an increase in the risk of Clostridium difficile infection (CDI) finds a study in BioMed Centrals open access journal BMC Medicine. Awareness of this link should improve ...
Background: Clostridium difficile infection is increasing in incidence, severity, and mortality (1). Surgery is sometimes used to manage complicated infections because it improves short-term survival (2); however, it is associated with high rates of morbidity and poor long-term survival (3). Surgery is most often used when disease recurs and cannot be controlled with antibiotics, because the risk for severe complications and mortality increases greatly during these recurrences (4). An alternative effective treatment for recurrent disease involves delivery of stool from a healthy donor directly into a patients colon. This procedure is known as fecal microbiota transplantation (FMT), and it can be done via enema or colonoscopy or indirectly into the colon through the upper gastrointestinal tract using various methods (5 ...
This episode discussed the difference between probiotics, synbiotics and prebiotics as well as information on probiotics. I also discuss antibiotic induced Clostridium difficile infections also known as C. Diff infections. Remember that the toxin produced by this bacteria is what causes the symptoms and issues with this infection. It can ...
BackgroundThe incidence and severity of Clostridium difficile infections are increasing. Acid-suppressive therapy has been suggested as a risk factor for C diff
Tangiisura, B, Davies, J G, Cheek, L, Rajkumar, C and Llewelyn, M (2010) Diagnosis of Clostridium difficile infection is associated with a small increased risk of death in elderly inpatients. Journal of Hospital Infection, 74 (4). pp. 401-3. ISSN 0195-6701 Full text not available from this repository ...
Clostridium difficile infection was more prevalent in patients undergoing allogeneic stem cell transplantation compared with patients undergoing autologous stem cell transplantation, according to findings published in Infection Control & Hospital Epidemiology.
Clostridium Difficile Infections Treatment Market - Industry Value Forecast, Dynamics, growth, potential, segments, market share, Size, online PDF Report, Free Sample Copy, Future projection, Analysis, supply and demand, trends, opportunities, Product types, Regions, current market, worth, overview, Competition Landscape and Dashboard.
Global Clostridium Difficile Infection Treatment Market is set to surpass from US$ 752.3 Mn in 2016 to US$ 1,316.7 Mn by 2025 end, with a healthy CAGR of 6.5% during the forecast period 2017-2025.
A novel approach to prevent C. difficile infection is to use compounds with activity against C. difficile as primary prophylaxis in high risk patients. Chemoprophylaxis theoretically can prevent C. difficile infection by two mechanisms. It may reduce transmission from asymptomatic C. difficile carriers by reducing the number of spores shed in the stool and prevent replication and subsequent toxin production of the organisms in patients at risk for C. difficile infection ...
C. difficile infections occur when someone is taking antibiotics.. The antibiotics destroy the good bacteria that usually protect patients, leaving C. difficile bacteria to take over.. Essentially the symptoms are diarrhea. That may not sound too bad, but for the elderly it can be deadly. The CDC associates C. difficile with 14,000 deaths a year.. The bacteria can be killed relatively easily, ironically enough with antibiotics. But the spores are hardy.. The author of the report, CDC epidemiologist Dr. Clifford McDonald, says the spores arent killed by hand washing - even with antibacterial soap - and they can last months out in the open.. "In the past a lot of C. difficle infections were considered to happen just generally in the community. But this report shows that most of these so called community infections actually occur in people with recent exposure to medical facilities.". Dr. Ileana Arias, the deputy director of the CDC, says the good news is that C. difficile infections are very ...
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.
What is C. difficile? C. difficile (Clostridium difficile) is a bacteria that can either live in the bowel as part of normal bowel flora without causing harm, or it can cause an infection (diarrhea, fever, abdominal pain).
Annual counts and rates of C. difficile infections by acute trust and clinical commissioning group (CCG) in patients aged 2 years and over.
Clinical cure is resolution or improvement of symptoms and signs of C. difficile infection such that additional or alternative antimicrobial therapy or other theraperutic intervention is not needed. In addition, patient must have absence of fever for two consecutive days and ,3 non-lliquid stools per day for two consecutive ...
RESULTS: Twenty-two patients were included, most of whom were male (55%) with a mean age of 58 years (range: 20-83 yrs). The most common underlying malignancies were nine patients with lymphoma (41%), seven with leukemia (32%), and six with solid tumors (27%). Indications for FDX included recurrent CDI in 16 patients (72%) and failure of both metronidazole and oral vancomycin in 6 patients (28%). Nineteen patients (86%) were on concomitant antimicrobials during CDI treatment. Clinical response to FDX was 91%, and overall sustained clinical response was 82%. FDX was well tolerated with no major adverse events that were FDX related or discontinuations due to drug-related adverse events ...
Prolongation of length of stay and |i|Clostridium difficile|/i| infection: A review of the methods used to examine length of stay due to healthcare associated infections
Panelists Peter L. Salgo, MD; Yoav Golan, MD, MS; Erik Dubberke, MD; Lawrence J. Brandt, MD; Dale N. Gerding, MD; and Daniel E. Freedberg, MD, MS, provide an overview of |em|Clostridium difficile|/em| and highlight common presenting factors of the disease in hospital settings and community practices.
Am J Gastroenterol 2015 Mar. has an interesting article on Clostridium difficile colonization and interesting finding based on data meta-analysis byDouglas K. Rex, MD reviewing Zacharioudakis IM et al. In a meta-analysis, risk for clinical Clostridium difficile infection was increased six fold in those who were colonized when admitted. Early studies suggested that Clostridium difficile […]. Read More ...
Clostridium difficileis a spore-forming, toxin-producing, gram-positive anaerobic bacterium that causes antibiotic-associated colitis. It colonizes the human intestinal tract after the normal gut flora has been altered by antibiotic therapy.C. diffic
Clostridium difficile infection (CDI) is a potentially fatal bacterial infection that leads to 3,700 deaths a year in Europe, yet almost two-thirds of CDI cases are missed because clinicians fail to request tests for C. difficile toxins. When CDI remains undiagnosed and untreated, it not only endangers patients health, it also poses a serious cost to healthcare systems.
METHODS: Data for this study were obtained from the U.S. National Hospital Discharge Surveys from 2001 to 2010. Eligible patients included those at least 18 years old with a discharge diagnosis of cancer (ICD-9-CM codes 140-165.X, 170-176.X, 179-189.X, 190-209.XX). CDI was identified using ICD-9-CM code 008.45. Data weights were applied to sampled patients to provide national estimates. CDI incidence was calculated as CDI discharges per 1000 total cancer discharges. The in-hospital mortality rate and hospital length of stay (LOS) were compared between cancer patients with and without CDI using bivariable analyses ...
Vienna (ots/PRNewswire) - CDI is one of the top ten hospital-acquired infections (HAIs) in European Hospitals[1] and is estimated to be three times as deadly as MRSA[2],[3] Data...
Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis - Gastroenterology (free). Source: EvidenceAlerts (free resource to find articles of interest). In this meta-analysis including 19 randomized trials, probiotics given within 2 days of the first antibiotic dose (more effective than if started later) reduced the risk of Clostridium difficile infection (CDI) by ,50% in hospitalized adults. 1 case of CDI would be prevented for every 23−144 patients treated with probiotics when antibiotics are started. "There was no convincing evidence of superior efficacy for any of the tested probiotic formulations, delivery methods (drink or capsule), or probiotic doses".. ...
Background: Clostridium difficile infection (CDI) is one of the most common nosocomial infections in the United States. The incidence of CDI in children has increased significantly in the last 20 years and up to 35% of pediatric patients develop recurrent infections. Therefore, it is imperative to further analyze the incidence and relapse rates of CDI in the pediatric population and determine the most effective treatment modalities. Methods: This was a retrospective cohort study for patients aged 1-21 years treated for CDI at our institution from January 2010 - December 2014 Results: We identified 201 patients, accounting for 231 separate episodes of CDI. Fourteen percent of those with CDI had known or were found to have IBD. Roughly 36% of patients were immunocompromised, and 49% had recent antibiotic exposure. Ten to 14 days of oral metronidazole was the most common initial treatment (70%) followed by vancomycin monotherapy (15%) and combination therapy (12%). About 28% of cases had at least ...
Purpose of review To provide a review of literature that discusses some of the most successful antimicrobial stewardship interventions reported across institutions worldwide in response to increased ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Joyanna M. Wendt, Jessica A. Cohen, Yi Mu, Ghinwa K. Dumyati, John R. Dunn, Stacy M. Holzbauer, Lisa G. Winston, Helen L. Johnston, James I. Meek, Monica M. Farley, Lucy E. Wilson, Erin C. Phipps, Zintars G. Beldavs, Dale N. Gerding, L. Clifford McDonald, Carolyn V. Gould, Fernanda C. Lessa ...
Experiment is an online platform for funding and sharing scientific discoveries. Push the boundaries of knowledge in biology, chemistry, medicine, physics, computer science, paleontology, economics, engineering, neuroscience, and more.
Too much zinc in the diet may alter gut microbiota, increasing susceptibility to Clostridium difficile infection, especially for those using antibiotics.
Fidaxomicin was highly effective in patients with cancer treated for the first episode of C. difficile infection (CDI) after failure of standard therapy and in patients with recurrent CDI, results of a study presented at IDWeek 2013.
What is Clostridium difficile (C. difficile)? Clostridium difficile (C. difficile) is a bacterium that is related to the bacterium that cause tetanus and botuli
Nicole Le Saux is Associate Professor in the Division of Infectious Diseases at the University of Ottawa *. As physicians we should be concerned about the inappropriate use of antibiotics. Have you ever had a patient with an extended spectrum beta-lactamase (ESBL), E. coli or Klebsiella urinary tract infection, a Clostridium difficile infection (CDI) or a drug-resistant N. gonorrhoeae?. Whereas resistant bacteria and CDI were rare a decade ago, these clinical situations are now commonplace in hospitals, long term care facilities and emergency departments. According to the the rate of CDI in hospitalized patients is 3.4 cases per 1000 patient admissions (approximately one in every 300 patients admitted). As of 2014, 18.2% of isolates of Neisseria gonorrhoeae were resistant to penicillin with worrisome decreased susceptibility to cefixime, ceftriaxone and azithromycin. ...continue reading →. ...
Clostridium difficile ATCC ® BAA-1382D-5™ Designation: Genomic DNA from Clostridium difficile Strain 630 TypeStrain=False Application:
Abstract The epidemiology of Clostridium difficile infection (CDI) has changed in recent years, with the occurrence of large outbreaks of infection associated with the emergence of..
This book outlines the currently available clinical, epidemiological and experimental data on Clostridium difficile infection (CDI) with special emphasis on studies and results achieved in Europe. Th
Merck & Co is gearing up to file its investigational antitoxin bezlotoxumab in the US, Canada and Europe this year, after late-stage data backed the drugs use in preventing the recurrence of Clostridium difficile infection. - News - PharmaTimes
To determine accuracy of measures of deaths attributable to Clostridium difficile infection, we compared 3 measures for 2007-2008 in Ontario, Canada: death certificate; death within 30 days of infection; and panel review. Data on death within 30 days ...
Rabbit polyclonal antibody raised against synthetic peptide of Clostridium difficile protein CD1021. A synthetic peptide corresponding to N-terminus of Clostridium difficile protein CD1021. (PAB16071) - Products - Abnova
In a presentation, You are What You Eat: Clostridium difficile and You, at the annual SHEA scientific meeting held earlier this week, Curtis Donskey, MD, of the Louis Stokes Cleveland Veterans Affairs Medical Center, reviewed the sources of Clostridium difficile transmission. Infected patients are the major reservoir for transmission of Clostridium difficile infection (CDI),
Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in the hamster gut after treatment with antibiotics and exposure to Clostridium difficile. C. difficile infection is typically lethal in hamsters, but protection can be conferred with neutralizing antibodies against the A and B toxins. We compare treatment with neutralizing monoclonal antibodies (mAb) to treatment with vancomycin, which prolongs the lives of animals but ultimately fails to protect them from death. We carried out longitudinal deep sequencing analysis and found distinctive waves of succession associated with each form of treatment. Clindamycin sensitization prior to infection was associated with the temporary suppression of the previously dominant Bacteroidales and the fungus Saccinobaculus in favor
If you are concerned about C. difficile Infections being battled in Hospitals today review the Abstract and Scientific evidence from the 2015 BETR-D Study ....adding UV light to bleach in rooms linked to C. difficile had no effect, Dr. Deverick J. Anderson, MD, MPH, FIDSA, FSHEA reported MedPage Today http://www.medpagetoday.com/meetingcoverage/idweek/54043 Adding ultraviolet light…
Clostridium difficile is a pathogen on the move, as evidenced by the rapid transcontinental spread of the so-called hypervirulent 027 strains, followed by the emergence of further PCR ribotypes such as 017, 078 and 106. This provides a rare opportunity to study the evolution of virulence in action. However, to fully exploit this opportunity, robust phylogenetic methods on a diverse set of characterised strains are required to provide a reference evolutionary framework to study C. difficile epidemiology, ecology and virulence. Traditional phylogenetic classification of bacteria to study evolutionary relatedness is based on the characterisation of a limited number of genes, rRNA or signature sequences. However, due to the acquisition of DNA through lateral gene transfer, the differences between closely related bacterial strains can be vast. By contrast, whole genome sequencing comparisons allow all genes to be compared. Nevertheless, whole-scale genome sequencing remains an expensive endeavour and ...
Clostridium difficile (C. difficile) causes life-threatening diarrhea. Clostridium difficile infection (CDI) is a leading cause of hospital associated gastrointestinal illness. This infections mostly occur in people who have had recent medical…. ...
Clostridium difficile infection (CDI) is a symptomatic infectious disease caused by the anaerobic, spore-forming bacterium called Clostridium difficile. Recently CDI has become increasingly prevalent worldwide. The severity of the infection is also on the rise, meaning the requirement for a rapid and accurate method of diagnosis [...]. ...
Clostridium difficile infection (CDI) is a symptomatic infectious disease caused by the anaerobic, spore-forming bacterium called Clostridium difficile. Recently CDI has become increasingly prevalent worldwide. The severity of the infection is also on the rise, meaning the requirement for a rapid and accurate method of diagnosis [...]. ...
A stay in the hospital may not be the only way to acquire Clostridium difficile diarrhea - but the potentially life-threatening infection may be associated with a number of health complications in hospitalized children, ...
Clostridium difficile is the leading cause of hospital acquired diarrhoea. With extended hospitalisation, a high mortality rate and the risk of recurrence, C. difficile infection presents a burden to both patients and the healthcare system. Symptoms of disease are primarily mediated by the two major toxins released by C. difficile and are the focus of current vaccine studies. Little is known of surface proteins in C. difficile, their role in colonisation and their potential as antigens to reduce severity of disease. The surface of C. difficile is composed of a peptidoglycan cell wall and an external S-layer. In many Gram positive bacteria a membrane bound enzyme, sortase, covalently attaches specific proteins to the cell wall. In this study, seven potential sortase substrates were identified and shown to be expressed in C. difficile 630, and at least four were shown to be localised to the cell wall. The substrate CD0183 was shown to need its LPxTG like domain for correct sorting onto the cell ...
Clostridium difficile is a Gram-positive, spore-forming, obligate anaerobe that has become the leading cause of nosocomial diarrhea in the United States. Infect...
PubMed journal article Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trial were found in PRIME PubMed. Download Prime PubMed App to iPhone or iPad.
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of C. difficile and C. difficile spores. Methods for the treatment, prophylaxis and prevention of C. difficile infection and disease in animals, including humans, are described.
Clostridium difficile infects hundreds of thousands of people a year and is becoming increasingly difficult to treat. While investigating a C. difficile-specific antimicrobial derived from a genetically modified bacteriocin, Kirk et al. isolated strains resistant to the treatment, which were found to have mutations in the surface layer. The mutants had defensive defects and attenuated virulence but were still able to colonize the gut of hamsters. In addition to revealing biology about C. difficile, these findings showcase how making targeted antimicrobials can force bacteria into forgoing virulence in favor of survival. ...
Clostridium difficile (C. difficile) is a bacterium that is the most common pathogen causing diarrhoea in hospitalised patients and residents of aged care
Researchers at the University of California, Davis suggest that reliance on only molecular tests to diagnose Clostridium difficile infection (CDI) without tests for toxins or host responses appears to result in overdiagnosis, overtreatment, and increased healthcare costs for CDI. For the study, all CDI-related complications and deaths among hospitalized patients occurred in those with toxin immunoassay results. Patients with positive molecular test results but negative toxin immunoassay results had outcomes similar to those without CDI.. Source: JAMA Internal Medicine, September 8, 2015 (online).. ...
Clostridium difficile is a Gram-positive spore-forming anaerobic bacillus found in the environment. Its spores are part of the colonic flora in about 2 to 3% of healthy adults, with colonization rates increasing during hospitalization to 20 to 40%. Disease occurs when the organism shifts to its replicating vegetative form with toxin (A and B) production, this typically happening when there is inhibition of the competing colonic flora by antibiotics. ...
Epidemiological surveillance of Clostridium difficile in human and animal health CEI Campus Moncloa: Campus of international Excellence
Correction: Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model. . Biblioteca virtual para leer y descargar libros, documentos, trabajos y tesis universitarias en PDF. Material universiario, documentación y tareas realizadas por universitarios en nuestra biblioteca. Para descargar gratis y para leer online.
Citation : Anthony, D. M., Reynolds, T., Payton, J. and Rafter, L. (2009) Serum albumin in risk assessment of clostridium difficile. Journal of Hospital Infection, 71 (4), pp. 378-9. ...
The most serious cases of hospital superbug Clostridium difficile have soared almost threefold in just over a decade, a study shows.
Have you learned about Clostridium Difficile? Test your knowledge on this science quiz to see how you do and compare your score to others. Quiz by JOSHR2004
It is believed that Clostridium difficile infection (CDI) contributes to a prolonged of length of stay (LOS). Recent literature suggests that models
In a study of US hospital patients, use of __________ was found to increase the odds of hospital-onset Clostridium difficile infection (HO CDI). ...
Clostridium perfringens (C. perfringens) is related to gram-positive and anaerobic bacteria. This rod-shaped bacterium produces spores and can cause a wide spectrum of diseases in humans and animals. Every of five different bacterium types can lead to different diseases. Most of distinct bacterial recognition methods are not completely effective and practical ...
Health,... ANN ARBOR Mich. Clostridium difficile a wily familiar bact... The deeper knowledge should lead to better prevention measures treat... If we can identify a deficiency in the host response we may be able ... C. difficile infections have doubled and grown more severe in r...,U-M,launches,effort,to,conquer,common,hospital-acquired,infection,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
A group of leading scientists from across Europe have launched a three-year project aimed at developing an oral vaccine against Clostridium difficile, an infection that kills around 4,000 people a year (almost four-times more than MRSA) and for which there is currently no effective treatments. While normally harmless in healthy people, the C. difficile bacteria…
In critically ill patients admitted to the ICU, diarrhea (defined as three or more watery loose stools within 24 hours) is a common problem. The etiologies of d
Sigma-Aldrich offers abstracts and full-text articles by [Tina Pirš, Jana Avberšek, Irena Zdovc, Brane Krt, Alenka Andlovic, Tatjana Lejko-Zupanc, Maja Rupnik, Matjaž Ocepek].
Infectious Disease Advisor is used by specialists and other medical professionals to help understand and treat infectious diseases. Latest news, research and treatment articles.
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections. This search facility features: flexible search syntax; automatic word stemming and relevance ranking; as well as graphical results.
We previously reported Clostridium difficile in 20% of retail meat in Canada, which raised concerns about potential foodborne transmissibility. Here, we studied the genetic diversity of C. difficile in retail meats, using a broad Canadian sampling infrastructure and 3 culture methods. We found 6.1% prevalence and indications of possible seasonality (highest prevalence in winter ...
The genome of an infant who lived in Alaska thousands of years ago represents a previously unknown group of humans called Ancient Beringians, who share a common lineage with other Native Americans. 0 Comments. ...
Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.. ...
Activating genes for reprogramming factors for a short time transforms large numbers of differentiated cells into multipotent forms that could be useful for cell-based therapies.. 0 Comments. ...
Editors note: This interesting article describes new research in which a type of bacteria called C. novyi was modified by researchers and injected into a soft tissue cancer patient to shrink a metastatic tumor in her arm. Ongoing research aims to determine which other kinds of cancer patients might benefit from the new treatment.. "A modified version of the Clostridium novyi (C. noyvi-NT) bacterium can produce a strong and precisely targeted anti-tumor response in rats, dogs and now humans, according to a new report from Johns Hopkins Kimmel Cancer Center researchers.. "In its natural form, C. novyi is found in the soil and, in certain cases, can cause tissue-damaging infection in cattle, sheep and humans. The microbe thrives only in oxygen-poor environments, which makes it a targeted means of destroying oxygen-starved cells in tumors that are difficult to treat with chemotherapy and radiation. The Johns Hopkins team removed one of the bacterias toxin-producing genes to make it safer for ...
In this study the researchers performed a range of experiments to look at a range of biological and chemical mechanisms behind the bodys defences against the bacteria C. difficile.. The researchers started by creating an animal "model" of C. difficile infection that they could study. To do this they injected purified TcdA toxin into the small intestines of mice. Previous work has suggested that the body limits the toxic effects of C. difficile by using a process called nitrosylation, which chemically modifies proteins.. To further explore the role of nitrosylation the researchers looked at the levels of a chemical called S-nitrosogluthathione (GSNO), which is often required for nitrosylation to take place. To do so, they compared levels of GSNO areas of the gut of mice that had been injected with the toxin and in areas left uninfected. They also looked at the levels of modified (nitrosylated) proteins in infected and uninfected gut tissues. The researchers also identified which specific ...
TORONTO — When it comes to treating Clostridium difficile with a fecal transplant — yes, human poop — swallowing a frozen capsule appears to have far less of an “ick factor” and works as well as delivering the therapy via colonoscopy, researchers say.
Scientists introduced Clostridium novyi, a bacteria that causes mild illnesses in humans that typically lurks inside the soil and feces, in cancer tumors a
Pet dogs have helped researchers show that a special bacteria can seemingly fight cancer, causing tumors to shrink. A modified version of Clostridium novyi bact
Researchers describe how the global epidemic of Clostridium difficile in the mid-2000s was caused when two separate strains of the pathogen emerged from north America. These had independently acquired resistance to a frontline antibiotic. This resistance drove the spread of C. difficile over large geographical distances, even from continent to continent.
Swap CDIs. If you already know how, thats good. Youll need to remove your original CDI from your ATV. To do this, pull the CDI unit out of your ATV so that it is only connected by the cable. Now, pull out the cable that is connected to the CDI from the ATV. Move your unplugged CDI out of the way. Install the spare CDI into your ATV. Take your working CDI and plug its cable into the input on the ATV. Since youll be using it for testing, theres not need to put it into place on the ATV ...
中川 莉彩 , 飯沼 由嗣 , 山本 正樹 , 松村 康史 , 白野 倫徳 , 松島 晶 , 長尾 美紀 , 斉藤 崇 , 高倉 俊二 , 伊藤 穣 , 樋口 武史 , 田中 美智男 , 一山 智 感染症学雑誌 : 日本伝染病学会機関誌 : the journal of the Japanese Association for Infectious Diseases 84(2), 147-152, 2010-03-20 医中誌Web 参考文献20件 被引用文献2件 ...
Just as the name implies, Clostridium difficile is a difficult pathogen to beat. It causes a nasty infection in your gut, and it's often resistant to
Clostridium difficile infection (CDI) is a symptomatic infection due to the spore-forming bacterium, Clostridium difficile. Symptoms include watery diarrhea, fever, nausea, and abdominal pain. It makes up about 20% of cases of antibiotic-associated diarrhea. Complications may include pseudomembranous colitis, toxic megacolon, perforation of the colon, and sepsis. Clostridium difficile infection is spread by bacterial spores found within feces. Surfaces may become contaminated with the spores with further spread occurring via the hands of healthcare workers. Risk factors for infection include antibiotic or proton pump inhibitors use, hospitalization, other health problems, and older age. Diagnosis is by stool culture or testing for the bacterias DNA or toxins. If a person tests positive but has no symptoms it is known as C. difficile colonization rather than an infection. Prevention is by limiting antibiotic use; and by hand washing, and terminal room cleaning in hospital. Discontinuation of ...
Synonyms for enteritis necroticans in Free Thesaurus. Antonyms for enteritis necroticans. 4 words related to enteritis: inflammation, redness, rubor, necrotizing enteritis. What are synonyms for enteritis necroticans?
Results:. An outbreak of C. difficile-associated diarrhea was caused by a clonal isolate of clindamycin-resistant C. difficile and was associated with increased use of clindamycin. Hospital-wide requirement of approval by an infectious disease consultant of clindamycin use led to an overall reduction in clindamycin use, a sustained reduction in the mean number of cases of C. difficile-associated diarrhea (11.5 cases/month compared with 3.33 cases/month; P , 0.001), and an increase in clindamycin susceptibility among C. difficile isolates (9% compared with 61%; P , 0.001). A parallel increase was noted in the use of and costs associated with other antibiotics with antianaerobic activity, including cefotetan, ticarcillin-clavulanate, and imipenem-cilastin. The hospital realized overall cost savings as a result of the decreased incidence of C. difficile-associated diarrhea. ...
TY - JOUR. T1 - Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection. T2 - A Retrospective Cohort Study. AU - Korayem, G. B.. AU - Eljaaly, K.. AU - Matthias, K. R.. AU - Zangeneh, T. T.. PY - 2018/1/1. Y1 - 2018/1/1. N2 - Introduction: Solid organ transplant (SOT) recipients are at high risk of Clostridium difficile infection (CDI) and CDI recurrence due to their suppressed immune systems and antibiotic exposure. A combination of metronidazole and oral vancomycin is often prescribed for SOT recipients with uncomplicated CDI despite any clinical practice guidelines supporting the need for combination therapy. This study aims to compare the CDI recurrence rates of metronidazole/vancomycin combination therapy to oral vancomycin monotherapy in SOT recipients after a first episode of uncomplicated CDI. Methods: A single-center retrospective cohort study evaluated SOT recipients diagnosed with uncomplicated CDI ...
Manuka honey originates from the manuka tree (Leptospermum scoparium) and its antimicrobial effect has been attributed to a property referred to as Unique Manuka Factor that is absent in other types of honey. Antibacterial activity of Manuka honey has been documented for several bacterial pathogens, however there is no information on Clostridium difficile, an important nosocomial pathogen. In this study we investigated susceptibility of C. difficile to Manuka honey and whether the activity is bactericidal or bacteriostatic. Three C. difficile strains were subjected to the broth dilution method to determine minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) for Manuka honey. The agar well diffusion method was also used to investigate sensitivity of the C. difficile strains to Manuka honey. The MIC values of the three C. difficile strains were the same (6.25% v/v). Similarly, MBC values of the three C. difficile strains were the same (6.25% v/v). The activity of Manuka
The hospital environment has been suggested as playing an important role in the transmission of hospital-associated (HA) pathogens. However, studies investigating the contamination of the hospital environment with methicillin-resistant Staphylococcus aureus (MRSA) or Clostridium difficile have generally focused on point prevalence studies of only a single pathogen. Research evaluating the roles of these two pathogens, concurrently, in the general hospital environment has not been conducted. The objectives of this study were to determine the prevalence and identify risk factors associated with MRSA and C. difficile contamination in the general environment of three community hospitals, prospectively. Sampling of environmental surfaces distributed over the medicine and surgical wards at each hospital was conducted once a week for four consecutive weeks. Sterile electrostatic cloths were used for environmental sampling and information regarding the surface sampled was recorded. For MRSA, air sampling was
Fast Shipping. Great Low Price. 7-way blackleg plus red water protection for cattle and sheep. For prevention of Clostridium chauvoei, septicum, novyi, sordellii, perfringens Types C & D, plus haemolyticum (bacillary hemoglobinuria/red water). Give cattle and sheep 2 ml SQ. Repeat in 3-4 weeks and once annually.Vision-8 with Spur Cattle Sheep Vaccine Merck Blackleg New Adjuvant | Blackleg 7 8 Way | Cattle Va
The relationship between faecal toxin titre, histological evidence of pseudomembrane in the rectum, and severity of antibiotic-associated colitis has been analysed from data on 62 patients whose faeces contained Clostridium difficile toxin. There was a significant correlation between a toxin titre of 6400 or more and the presence of pseudomembrane (p less than 005). There was no correlation between toxin titre, duration of diarrhoea, total white cell count, temperature, serum albumin or serum orosomucoid concentrations. There was, however, a significant correlation between the presence of rectal pseudomembrane and duration of diarrhoea (p less than 0.005). Exposure to clindamycin or lincomycin was also associated with a significantly higher toxin titre than that seen in patients who were given other antibiotics. The duration of diarrhoea of diarrhoea was not longer and rectal pseudomembrane did not occur more often in the patients who had received clindamycin or lincomycin.. ...

Toxic MegacolonToxic Megacolon

A toxic megacolon is a rare yet life-threatening complication of severe colon disease or infection. It is diagnosed when your ... Colon infection. This can be caused by a bacteria (Clostridium difficile). This germ can lead to severe diarrhea. Other ... HIV infection or AIDS. For people with HIV, cytomegalovirus (CMV) colitis is the leading cause of toxic megacolon ... It can be a complication of severe colon disease or infection. It is rare, but life-threatening and needs treatment right away ...
more infohttp://healthlibrary.lomalindahealth.org/Library/DiseasesConditions/Adult/Digestive/134,180

Buy Metronidazole Online. Metronidazole And Alcohol | General Wine and Food Topics | Forum | WineInfo.comBuy Metronidazole Online. Metronidazole And Alcohol | General Wine and Food Topics | Forum | WineInfo.com

metronidazole rash.metronidazole dosage sinus infection.chemical name metronidazole.metronidazole rectal enema.what is the ... is metronidazole prescribed for.metronidazole and side effects.acute metronidazole allergies.canine diarrhea clostridium ... can you take augmentin with metronidazole.metronidazole for sinus infection.metronidazole.metronidazole for pets.metronidazole. ... metronidazole for cats.metronidazole.mp45 metronidazole.metronidazole and anemia.metronidazole cause yeast infection. ...
more infohttp://wineinfo.com/forum/general-wine-and-food-topics/buy-metronidazole-online-metronidazole-and-alcohol/

Clostridioides difficile Infection | HAI | CDCClostridioides difficile Infection | HAI | CDC

Clostridium Sordellii. * Carbapenem-resistant Enterobacteriaceae (CRE)plus icon *Patients. *Clinicians. *Healthcare Facilities ... Types of Infectionsplus icon * Central Line-associated Bloodstream Infectionsplus icon *Resources for Patients & Providers ... Healthcare Environmental Infection Preventionplus icon *Reduce Risk from Water. *Environmental Cleaning in Resource-Limited ... Infection Control Assessment Tools. * Environmental Cleaning in Resource-Limited Settingsplus icon *Key Definitions & ...
more infohttp://www.cdc.gov/HAI/organisms/cdiff/Cdiff_infect.html

Clostridium Infections | GreenMedInfo | Disease | Natural MedicineClostridium Infections | GreenMedInfo | Disease | Natural Medicine

Bacillus subtilis infections, Clostridium Infections, Escherichia coli Infections, Fungal Infection, Klebsiella Infections, ... Diseases : Clostridium Infections, Enterococcus Infections, Infection: Antibiotic Resistant, Klebsiella Infections, ... Diseases : Bacillus Cereus infection, Clostridium Infections, Listeria Infections, Salmonella Infections, Staphylococcus aureus ... Diseases : Clostridium Infections, Fungal Infection, Urinary Tract Infections. Additional Keywords : Natural Substances Versus ...
more infohttps://www.greenmedinfo.com/disease/clostridium-infections

COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM INFECTION AND PREVENTING RECURRENCE OF INFECTION - UNIVERSITY OF VIRGINIA...COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM INFECTION AND PREVENTING RECURRENCE OF INFECTION - UNIVERSITY OF VIRGINIA...

i,C. difficile ,/i,infection (CDI) is the most common cause of antibiotic-associated diarrhea. Unfortunately, antibiotic ... Murine Infection Model of Clostridium difficile Infection Mice were infected with Clostridium difficile using a model of ... COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIUM INFECTION AND PREVENTING RECURRENCE OF INFECTION ... 1. A method of preventing or treating a Clostridium difficile (C. difficile) infection using a low dose of antibiotic, said ...
more infohttp://www.freepatentsonline.com/y2015/0133366.html

Vital Signs: Preventing Clostridium difficile InfectionsVital Signs: Preventing Clostridium difficile Infections

... Abstract. Background: Clostridium difficile infection (CDI) is a ... TABLE 2. Reductions in hospital-onset Clostridium difficile infection rates - Illinois, Massachusetts, and New York, May 2008- ... FIGURE 2. Percentage of laboratory-identified Clostridium difficile infections (N = 42,157), by hospitalization status at time ... TABLE 1. Number and percentage of hospitals reporting laboratory-identified Clostridium difficile infections, by selected ...
more infohttp://www.cdc.gov/mmwr/preview/mmwrhtml/mm61e0306a1.htm?s_cid=mm61e0306a1_w

Compositions and methods for treating clostridium infection and preventing recurrence of infection - PatentCompositions and methods for treating clostridium infection and preventing recurrence of infection - Patent

... treatment is sufficient to treat the disease and prevent recurrent disease by enabling a good immunologic response to infection ... difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea. Unfortunately, antibiotic therapy remains ... Compositions and methods for treating clostridium infection and preventing recurrence of infection Patent Number: 9387199 ... C. difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea. Unfortunately, antibiotic therapy ...
more infohttps://www.findownersearch.com/compositions-and-methods-for-treating-clostridium-infection-and-preventing-recurrence-of-infection-9387199-patent.html

Tea and Recurrent Clostridium difficile InfectionTea and Recurrent Clostridium difficile Infection

"Meta-analysis to assess risk factors for recurrent Clostridium difficile infection," Journal of Hospital Infection, vol. 70, no ... Tea and Recurrent Clostridium difficile Infection. Martin Oman Evans II,1 Brad Starley,2 Jack Carl Galagan,3 Joseph Michael ... J. S. Weese, "Clostridium difficile in food-innocent bystander or serious threat?" Clinical Microbiology and Infection, vol. 16 ... The incidence of Clostridium difficile infection (CDI) is on the rise and has increased by a factor of three over the last ...
more infohttps://www.hindawi.com/journals/grp/2016/4514687/

Clostridium Difficile Infections (Clostridium Difficile AssociatedClostridium Difficile Infections (Clostridium Difficile Associated

Clostridium Difficile Associated Disease) - Pipeline Review, H1 2014 Summary Global Markets Directs, Clostridium Difficile ... New Market Report: Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 2014. New ... Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013. - Dementia Associated ... Global Markets Directs, Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 ...
more infohttp://www.sbwire.com/press-releases/new-market-report-clostridium-difficile-infections-clostridium-difficile-associated-disease-pipeline-review-h1-2014-505546.htm

CDC Warns Of Increasing Clostridium Difficile Infections .
        
        News
    
    | OPBCDC Warns Of Increasing Clostridium Difficile Infections . News | OPB

CDC Warns Of Increasing Clostridium Difficile Infections. by Kristian Foden-Vencil Follow OPB March 6, 2012 7:25 a.m. , Updated ... The CDC studied infections in three states and has now developed a list of six things medical centers should do. ... C. difficile infections occur when someone is taking antibiotics.. The antibiotics destroy the good bacteria that usually ... "In the past a lot of C. difficle infections were considered to happen just generally in the community. But this report shows ...
more infohttps://www.opb.org/news/article/cdc-warns-increasing-clostridium-difficile-infections/

Treating Clostridium difficile infection with fecal microbiota transplantation.  - PubMed - NCBITreating Clostridium difficile infection with fecal microbiota transplantation. - PubMed - NCBI

Treating Clostridium difficile infection with fecal microbiota transplantation.. Bakken JS1, Borody T, Brandt LJ, Brill JV, ... Clostridium difficile infection is increasing in incidence, severity, and mortality. Treatment options are limited and appear ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/21871249?access_num=21871249&link_type=MED&dopt=Abstract

Clinical recognition and diagnosis of Clostridium difficile infection.  - PubMed - NCBIClinical recognition and diagnosis of Clostridium difficile infection. - PubMed - NCBI

Prompt and precise diagnosis is an important aspect of effective management of Clostridium difficile infection (CDI). CDI ... Clinical recognition and diagnosis of Clostridium difficile infection.. Bartlett JG1, Gerding DN. ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/18177217?dopt=Abstract

Clostridium difficile infection in adults: Clinical manifestations and diagnosisClostridium difficile infection in adults: Clinical manifestations and diagnosis

Clostridium difficileis a spore-forming, toxin-producing, gram-positive anaerobic bacterium that causes antibiotic-associated ... See Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology and Clostridium difficile infection: ... and Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology and Clostridium difficile infection: ... Clostridium difficile infection. N Engl J Med 2015; 372:1539.. *Goldenberg SD, Cliff PR, Smith S, et al. Two-step glutamate ...
more infohttp://www.uptodate.com/contents/clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis

Clostridium difficile Infection and Inflammatory Bowel Disease: A ReviewClostridium difficile Infection and Inflammatory Bowel Disease: A Review

"Review of current literature on the economic burden of Clostridium difficile infection," Infection Control and Hospital ... Clostridium difficile Infection and Inflammatory Bowel Disease: A Review. Preetika Sinh, Terrence A. Barrett, and Laura Yun ... C. P. Kelly and J. T. LaMont, "Clostridium difficile infection," Annual Review of Medicine, vol. 49, pp. 375-390, 1998. View at ... D. N. Gerding, C. A. Muto, and R. C. Owens, "Treatment of Clostridium difficile infection," Clinical Infectious Diseases, vol. ...
more infohttps://www.hindawi.com/journals/grp/2011/136064/

Treatment of recurrent Clostridium difficile infection: a systematic review | SpringerLinkTreatment of recurrent Clostridium difficile infection: a systematic review | SpringerLink

... recurs in nearly one-third of patients who develop an initial infection. Recurrent CDI (RCDI) is associated with considerable ... Clostridium difficile infection (CDI) recurs in nearly one-third of patients who develop an initial infection. Recurrent CDI ( ... A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2012;40:479-84. doi: ... Dubberke E. Strategies for prevention of Clostridium difficile infection. J Hosp Med. 2012;7:S14-7. doi: 10.1002/jhm.1908. ...
more infohttps://link.springer.com/article/10.1007%2Fs15010-013-0496-x

Update on the Management of Clostridium difficile InfectionUpdate on the Management of Clostridium difficile Infection

Preventing Clostridium difficile infections: an executive summary of the Association for Professionals in Infection Control and ... Update on the Management of Clostridium difficile Infection. Mariette Sourial, PharmD*. Assistant Professor of Pharmacy ... Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422-431. 19. Cornely OA, Crook DW, ... Clostridium difficile infection, including pseudomembranous colitis. In: Longo DL, Fauci AS, Kasper DL, et al, eds. Harrisons ...
more infohttps://www.uspharmacist.com/article/update-on-the-management-of-clostridium-difficile-infection

Common Questions About Clostridium difficile Infection - American Family PhysicianCommon Questions About Clostridium difficile Infection - American Family Physician

Mild C. difficile infection should be treated with oral metronidazole; severe infection should be treated with oral vancomycin ... Recurrences of the infection should be treated based on severity. Tapering and the pulsed-dose method of oral vancomycin ... C. difficile infection is also associated with older age, recent hospitalization, multiple comorbidities, use of gastric acid ... The most important modifiable risk factor for C. difficile infection is antibiotic exposure; this risk is dose-related and ...
more infohttps://www.aafp.org/afp/2014/0315/p437.html

Clostridium Difficile Infection (Ambulatory Care) - What You Need to KnowClostridium Difficile Infection (Ambulatory Care) - What You Need to Know

Care guide for Clostridium Difficile Infection (Ambulatory Care). Includes: possible causes, signs and symptoms, standard ... What you need to know about a Clostridium difficile infection (CDI):. Clostridium difficile, or C. diff, are bacteria. Many ... Prevent infections caused by bacteria. This will help prevent your need for an antibiotic. Ask about vaccines that you need. ... Wash your hands frequently to prevent the spread of infection.. *Ask your healthcare provider how to manage your symptoms ...
more infohttps://www.drugs.com/cg/clostridium-difficile-infection-ambulatory-care.html

PHC4 | Clostridium difficile Infections - Hospital Admissions in PAPHC4 | Clostridium difficile Infections - Hospital Admissions in PA

Clostridium difficile Infections - Hospital Admissions in PA. This brief focuses on hospitalizations related to Clostridium ... difficile Infections (CDI). These infections can cause severe suffering and can be life threatening. They are characterized by ...
more infohttp://www.phc4.org/reports/researchbriefs/cdi/17/

Identification of Toxemia in Patients with Clostridium difficile InfectionIdentification of Toxemia in Patients with Clostridium difficile Infection

Circumstantial evidence suggests that toxemia may occur in patients with C. difficile infection (CDI), but positive diagnosis ... Neutralizing anti-toxin antibodies were present during infection and positively correlated with the diagnosis limits. Thus, the ... Toxemia can develop in Clostridium difficile-infected animals, and correlates with severe and fulminant disease outcomes. ... Clostridium difficile infection (CDI) is a major cause of morbidity and mortality in hospitalized patients [1]. CDI is mainly ...
more infohttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0124235

Clostridium Difficile Infection - Renal and Urology NewsClostridium Difficile Infection - Renal and Urology News

Diarrhea is the key symptom of Clostridium difficile infection, with various degrees of abdominal cramping and pain in most ... Cohen, S, Gerding, DN, Johnson, S. "Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by ... Petrella, LR, Sambol, SP, Cheknis, A. "Decreased cure and increased recurrence rate for Clostridium difficile infection caused ... How did the patient develop CDI? What was the primary source from which the infection spread?. *. The source for C. difficile ...
more infohttps://www.renalandurologynews.com/infectious-diseases/clostridium-difficile-infection/article/609178/

Clostridium difficile infection - Renal and Urology NewsClostridium difficile infection - Renal and Urology News

"Clostridium difficile infection". N Engl J Med. vol. 372. 2015. pp. 1539-1548. (This is a nice review recently published at ... "Fidaxomicin versus vancomycin for Clostridium difficile infection". N Engl J Med. vol. 364. 2011. pp. 422-431. ... "Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections". Am J Gastroenterol. vol. 108. 2013. ... Diagnostic Confirmation: Are you sure your patient has Clostridium difficile infection (CDI)?. Detection of toxins by enzyme ...
more infohttps://www.renalandurologynews.com/home/decision-support-in-medicine/hospital-medicine/clostridium-difficile-infection-2/

Clostridium difficile Infection Among Children Across Diverse US Geographic Locations | Articles | PediatricsClostridium difficile Infection Among Children Across Diverse US Geographic Locations | Articles | Pediatrics

Clostridium difficile Infection Among Children Across Diverse US Geographic Locations. Joyanna M. Wendt, Jessica A. Cohen, Yi ... Clostridium difficile Infection Among Children Across Diverse US Geographic Locations. Joyanna M. Wendt, Jessica A. Cohen, Yi ... Clostridium difficile Infection Among Children Across Diverse US Geographic Locations Message Subject (Your Name) has sent you ...
more infohttp://pediatrics.aappublications.org/content/early/2014/02/25/peds.2013-3049.comments

Clostridium difficile Infection Among Children Across Diverse US Geographic Locations | Articles | PediatricsClostridium difficile Infection Among Children Across Diverse US Geographic Locations | Articles | Pediatrics

Measuring the scope of Clostridium difficile infection in the United States. Available at: www.cdc.gov/hai/eip/clostridium- ... Clostridium difficile Infection Among Children Across Diverse US Geographic Locations. Joyanna M. Wendt, Jessica A. Cohen, Yi ... Clostridium difficile infection. CA - community-associated. CO-HCFA - community-onset, health care facility-associated. EIP - ... Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61(9):157-162pmid:22398844. ...
more infohttp://pediatrics.aappublications.org/content/133/4/651

Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection | SpringerLinkPatient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection | SpringerLink

... is a severe and increasingly frequent healthcare-associated infection that develops after disruption of the gut microbiota. ... Clostridium difficile infection (CDI) is a severe and increasingly frequent healthcare-associated infection that develops after ... healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin- ... Clostridium difficile infection Fecal microbiota Fecal transplant Patient perspectives Patient reported outcomes Questionnaire ...
more infohttps://link.springer.com/article/10.1007/s40121-016-0106-1
  • major reductions will require antibiotic stewardship along with infection control applied to nursing homes and ambulatory-care settings as well as hospitals. (cdc.gov)
  • Population-based data from the Emerging Infections Program were analyzed by location and antecedent health-care exposures. (cdc.gov)
  • CDC's Emerging Infections Program conducted active, population-based surveillance for CDIs from eight diverse geographic areas in 2010 ( 5 ). (cdc.gov)
  • But this report shows that most of these so called community infections actually occur in people with recent exposure to medical facilities. (opb.org)
  • C. difficile infections that occur without a history of admission to a healthcare facility in the last 12 weeks are considered community-associated, and account for about 33% of CDI. (oregon.gov)
  • 7 These spores are ubiquitous, serving as a continuous source for infection through their tenacious adherence to fomites (i.e., bedding). (uspharmacist.com)
  • Postinfectious irritable bowel syndrome in a C. difficile carrier can be clinically indistinguishable from a relapse of C. difficile infection, though there should be an improving or normal white count and normal temperature curve. (renalandurologynews.com)
  • The majority of cases reported in 2005 were colonic IBD (91%) and outpatient acquired infections (76%) [ 6 ]. (hindawi.com)